摘要
目的 观察必可酮配伍思密达防治放射性口腔炎的疗效。方法 88例头颈部肿瘤放疗患者随机分成治疗组与对照组各 44例 ,治疗组采用必可酮配伍思密达 ,对照组采用朵贝氏液及VitB1治疗。结果 治疗组口腔炎发生率 3 8.6% ,对照组为 5 9.1% ;治疗组 3、4级口腔炎发生率为 6.8% ,对照组为 3 8.6% ,二者均有统计学差异 (P <0 .0 1)。
Objective To observe the effect of Beconase combined with Smecta to alleviate radiation induced oral mucositis. Methods 88 patients with carcinoma in head and neck were randomized into two groups. The study group (44 cases) was treated by Smecta combined with Beconase. The control group (44 cases) was received Dobell's sol plus vitB 1 . Results Mucositis was 38.6 %(17/44) in study group, 59.1 %(26/44) in the control group, respectively. Grade 3 and grade 4 mucositis was 6.8 %(3/44) in the study group, 38.6 %(17/44) in the control group, respectively, ( P < 0.01 ). Conclusion Beconase combined with Smecta is a effective method to alleviate radiation induced oral mucositis.
出处
《临床口腔医学杂志》
2002年第1期45-46,共2页
Journal of Clinical Stomatology
关键词
必可酮
思密达
放射性口腔炎
防治
配伍
Smecta
Beconase
radiotherapy mucositis
prevention and treatment
